Adam Maeder
Stock Analyst at Piper Sandler
(4.54)
# 1,005
Out of 4,581 analysts
356
Total ratings
53.5%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Reiterated: Buy | $100 → $101 | $83.68 | +20.70% | 56 | Jul 24, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $115 → $118 | $107.27 | +10.00% | 19 | Jul 17, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $580 → $470 | $361.80 | +29.91% | 50 | Jul 17, 2026 | |
| STAA STAAR Surgical Company | Maintained: Hold | $33 | $22.66 | +45.63% | 6 | Jul 17, 2026 | |
| NYXH Nyxoah | Maintained: Buy | $7 | $1.43 | +389.51% | 25 | Jul 9, 2026 | |
| RXST RxSight | Maintained: Hold | $10 | $6.05 | +65.29% | 9 | Jul 7, 2026 | |
| GKOS Glaukos | Reiterated: Buy | $165 | $151.33 | +9.03% | 16 | Jul 1, 2026 | |
| LIVN LivaNova | Maintained: Buy | $85 → $87 | $82.09 | +5.98% | 33 | Jun 23, 2026 | |
| STXS Stereotaxis | Reiterated: Buy | $4 → $3.5 | $1.28 | +173.44% | 18 | May 13, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $9 | $5.30 | +69.81% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $275 → $233 | $208.96 | +11.50% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.6845 | +338.28% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $27.74 | +51.41% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $85 → $55 | $51.97 | +5.83% | 49 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 → $3 | $1.87 | +60.43% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.5 → $7 | $0.10 | +6,900.00% | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $52.58 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.53 → $2.12 | $0.20 | n/a | 2 | Dec 23, 2019 |
Edwards Lifesciences
Jul 24, 2026
Reiterated: Buy
Price Target: $100 → $101
Current: $83.68
Upside: +20.70%
Abbott Laboratories
Jul 17, 2026
Reiterated: Buy
Price Target: $115 → $118
Current: $107.27
Upside: +10.00%
Intuitive Surgical
Jul 17, 2026
Reiterated: Buy
Price Target: $580 → $470
Current: $361.80
Upside: +29.91%
STAAR Surgical Company
Jul 17, 2026
Maintained: Hold
Price Target: $33
Current: $22.66
Upside: +45.63%
Nyxoah
Jul 9, 2026
Maintained: Buy
Price Target: $7
Current: $1.43
Upside: +389.51%
RxSight
Jul 7, 2026
Maintained: Hold
Price Target: $10
Current: $6.05
Upside: +65.29%
Glaukos
Jul 1, 2026
Reiterated: Buy
Price Target: $165
Current: $151.33
Upside: +9.03%
LivaNova
Jun 23, 2026
Maintained: Buy
Price Target: $85 → $87
Current: $82.09
Upside: +5.98%
Stereotaxis
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $1.28
Upside: +173.44%
Sight Sciences
May 7, 2026
Reiterated: Buy
Price Target: $9
Current: $5.30
Upside: +69.81%
May 6, 2026
Maintained: Hold
Price Target: $275 → $233
Current: $208.96
Upside: +11.50%
May 5, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $0.6845
Upside: +338.28%
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $27.74
Upside: +51.41%
May 5, 2026
Downgraded: Hold
Price Target: $85 → $55
Current: $51.97
Upside: +5.83%
Apr 7, 2026
Maintained: Buy
Price Target: $5.5 → $3
Current: $1.87
Upside: +60.43%
Aug 13, 2025
Maintained: Hold
Price Target: $8.5 → $7
Current: $0.10
Upside: +6,900.00%
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $52.58
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.53 → $2.12
Current: $0.20
Upside: n/a